Related Experiment Video

Updated: May 12, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis

Sandeep K Raghuwanshi1, Nikia Smith, Elizabeth J Rivers

  • 1Department of Biology, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|April 17, 2013
PubMed

Insights

G protein-coupled receptor kinases (GRKs) regulate cancer. GRK6 deficiency promotes lung cancer growth and metastasis by enhancing CXCR2 activity, leading to increased angiogenesis and tumor spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • G protein-coupled receptor kinases (GRKs) mediate G protein-coupled receptor (GPCR) desensitization.
  • GRK6 plays a role in regulating cellular responses via GPCRs, including the chemokine receptor CXCR2.
  • The role of GRK6 in tumorigenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the role of GRK6 in lung cancer progression and metastasis using murine models.
  • To elucidate the molecular mechanisms by which GRK6 influences tumor microenvironment and angiogenesis.
  • To examine the interplay between GRK6, β-arrestin-2, and CXCR2 in cancer development.

Main Methods:

  • Utilized GRK6-deficient (GRK6(-/-)) and wild-type (GRK6(+/+)) mice in Lewis lung cancer models.
  • Assessed tumor growth, metastasis, angiogenesis, and immune cell infiltration.
  • Developed and analyzed a double GRK6(-/-)/βarr2(-/-) knockout mouse model.
  • Investigated the effect of anti-CXCR2 antibody treatment on tumor growth.

Main Results:

  • GRK6(-/-) mice exhibited significantly increased lung cancer growth and metastasis compared to controls.
  • GRK6 deletion upregulated matrix metalloproteinase (MMP)-2 and MMP-9, increased tumor-infiltrating neutrophils (PMNs), and enhanced microvessel density.
  • Double GRK6(-/-)/βarr2(-/-) mice showed accelerated tumor growth, suggesting complex regulatory pathways.
  • Anti-CXCR2 antibody treatment inhibited tumor growth in both GRK6(-/-) and GRK6(-/-)/βarr2(-/-) mice.

Conclusions:

  • CXCR2 signaling, regulated by GRK6, is crucial for angiogenesis, tumor progression, and metastasis.
  • GRK6 deficiency enhances host CXCR2 activity, promoting PMN infiltration and MMP release, which fuels tumor growth.
  • CXCR2 engages distinct mechanisms to mediate tumor progression, involving both GRK6 and β-arrestin-2 pathways.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...